Aliases & Classifications for Salmonellosis

MalaCards integrated aliases for Salmonellosis:

Name: Salmonellosis 12 76 3 15 73
Salmonella Infections 55 43 73
Salmonella Infection 12

Classifications:



External Ids:

Disease Ontology 12 DOID:0060859
ICD10 33 A02.0 A02.8
ICD9CM 35 003.0

Summaries for Salmonellosis

MedlinePlus : 43 Salmonella is the name of a group of bacteria. In the United States, it is a common cause of foodborne illness. Salmonella occurs in raw poultry, eggs, beef, and sometimes on unwashed fruit and vegetables. You also can get infected after handling pets, especially reptiles like snakes, turtles, and lizards. Symptoms include Fever Diarrhea Abdominal cramps Headache Possible nausea, vomiting, and loss of appetite Symptoms usually last 4-7 days. Your health care provider diagnoses the infection with a stool test. Most people get better without treatment. Infection can be more serious in the elderly, infants, and people with chronic health problems. If Salmonella gets into the bloodstream, it can be serious. The usual treatment is antibiotics. Typhoid fever, a more serious disease caused by Salmonella, is not common in the United States. It frequently occurs in developing countries. NIH: National Institute of Allergy and Infectious Diseases

MalaCards based summary : Salmonellosis, also known as salmonella infections, is related to typhoid fever and schistosomiasis, and has symptoms including fever and pruritus. An important gene associated with Salmonellosis is IL12RB1 (Interleukin 12 Receptor Subunit Beta 1), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Azithromycin and Cefixime have been mentioned in the context of this disorder. Affiliated tissues include testes, t cells and liver, and related phenotypes are hematopoietic system and cellular

Disease Ontology : 12 A primary bacterial infectious disease caused by the bacteria of the genus Salmonella. It has sypmtoms diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. In most cases, the illness lasts four to seven days, and most people recover without treatment.

CDC : 3 CDC estimates Salmonella causes about 1.2 million illnesses, 23,000 hospitalizations, and 450 deaths in the United States every year. Food is the source for about 1 million of these illnesses.

Wikipedia : 76 Salmonellosis is a symptomatic infection caused by bacteria of the Salmonella type. The most common... more...

Related Diseases for Salmonellosis

Diseases related to Salmonellosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 165)
# Related Disease Score Top Affiliating Genes
1 typhoid fever 30.4 ALB CASP1 IFNG IFNGR1 IL1B SLC11A1
2 schistosomiasis 30.4 ALB IFNG IFNGR1
3 brucellosis 30.2 IFNG SLC11A1 TLR4
4 chagas disease 30.0 IFNG IL1B TLR4
5 pneumonia 29.9 IL1B LACTB TLR4
6 acquired immunodeficiency syndrome 29.9 ALB IFNG IL1B
7 cysticercosis 29.7 IL18 IL1B TLR4
8 crohn's disease 29.6 IL1B SLC11A1 TLR4
9 campylobacteriosis 29.3 IFNG IL1B JUN SLC11A1 STAT1 TLR4
10 lymphadenitis 28.0 IFNG IFNGR1 IL12RB1 IL18 IL1B SLC11A1
11 malaria 27.2 ALB CASP1 IFNG IFNGR1 IL18 IL1B
12 invasive non-typhoidal salmonellosis 12.0
13 immunodeficiency 30 11.2
14 immunodeficiency 27b 11.1
15 immunodeficiency 29 11.0
16 immunodeficiency 27a 10.9
17 interferon gamma, receptor 1, deficiency 10.9 IFNG IFNGR1
18 axillary adenitis 10.8 IL12RB1 STAT1
19 prosthetic joint infection 10.8 IL1B TLR4
20 variola major 10.8 IFNG TLR4
21 mycobacterium fortuitum 10.7 IFNGR1 IL12RB1 LACTB
22 macs syndrome 10.7 IFNGR1 IL12RB1 SLC11A1
23 staphylococcal toxic shock syndrome 10.7 IFNG IL1B
24 autoimmune myocarditis 10.7 IFNG IL1B
25 abdominal tuberculosis 10.6 ALB IL12RB1
26 coccidioidomycosis 10.6 IFNGR1 STAT1 TLR4
27 penicillin allergy 10.6 IFNG IFNGR1
28 q fever 10.5 IFNG IL1B TLR4
29 extrapulmonary tuberculosis 10.5 IFNG IL1B SLC11A1
30 bacterial vaginosis 10.5 DEFB4A IL1B TLR4
31 gastrointestinal tuberculosis 10.5 ALB IFNG
32 septic arthritis 10.5 DEFB4A IFNG TLR4
33 toxoplasmosis 10.5 IFNG IL1B TLR4
34 toxic shock syndrome 10.5 IFNG IL1B TLR4
35 meningitis and encephalitis 10.5 ALB CP
36 eumycotic mycetoma 10.5 DEFB4A IFNG IL1B
37 aggressive periodontitis 10.5 DEFB1 IL1B TLR4
38 immune deficiency disease 10.5 IFNG IFNGR1 IL12RB1
39 tonsillitis 10.4 DEFB1 IFNG IL1B
40 vulvovaginal candidiasis 10.4 DEFB1 DEFB4A IFNG
41 pyelonephritis 10.4 ALB IL1B TLR4
42 burns 10.4 ALB IL1B
43 periodontitis 10.4 IFNG IL1B TLR4
44 filariasis 10.4 ALB IFNG TLR4
45 eales disease 10.4 CP IFNG IL1B
46 mouth disease 10.4 IFNG IL1B STAT1
47 hypersensitivity reaction disease 10.3 ALB IFNG IL1B
48 chronic inflammatory demyelinating polyradiculoneuropathy 10.3 ALB IFNG STAT1
49 systemic onset juvenile idiopathic arthritis 10.3 IL18 IL1B
50 trypanosomiasis 10.3 ALB IFNG IL1B

Comorbidity relations with Salmonellosis via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Salmonellosis:



Diseases related to Salmonellosis

Symptoms & Phenotypes for Salmonellosis

UMLS symptoms related to Salmonellosis:


fever, pruritus

MGI Mouse Phenotypes related to Salmonellosis:

46 (show all 12)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.27 CP IL12RB1 IL18 NLRC4 TLR4 IFNG
2 cellular MP:0005384 10.24 JUN STAT1 CP NLRC4 IL18 IFNG
3 immune system MP:0005387 10.22 CP IL12RB1 IL18 NLRC4 TLR4 IFNG
4 homeostasis/metabolism MP:0005376 10.21 JUN STAT1 CP IL12RB1 IL18 IFNG
5 cardiovascular system MP:0005385 10.16 IFNGR1 JUN STAT1 CP IL18 IFNG
6 digestive/alimentary MP:0005381 10.08 STAT1 IL18 TLR4 SLC11A1 IFNG ALB
7 mortality/aging MP:0010768 10 CASP1 IFNGR1 JUN STAT1 SLC11A1 IL18
8 integument MP:0010771 9.97 IFNGR1 JUN STAT1 IL18 IFNG IL1B
9 liver/biliary system MP:0005370 9.92 CP TLR4 IFNG ALB SPI1 IFNGR1
10 neoplasm MP:0002006 9.81 TLR4 IFNG SLC11A1 ALB SPI1 IL1B
11 nervous system MP:0003631 9.65 IFNGR1 JUN STAT1 CP IL18 IFNG
12 vision/eye MP:0005391 9.17 JUN STAT1 CP IL18 IFNG SPI1

Drugs & Therapeutics for Salmonellosis

Drugs for Salmonellosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 44)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4 83905-01-5 55185 447043
2
Cefixime Approved, Investigational Phase 4 79350-37-1 54362 5362065
3
Ceftriaxone Approved Phase 4,Not Applicable 73384-59-5 5479530 5361919
4
Gatifloxacin Approved, Investigational Phase 4 112811-59-3 5379
5 Anti-Bacterial Agents Phase 4,Not Applicable
6 Antibiotics, Antitubercular Phase 4
7 Anti-Infective Agents Phase 4,Phase 1,Phase 2,Not Applicable
8 Antitubercular Agents Phase 4
9 Vaccines Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
10 Fluoroquinolones Phase 4
11 Nucleic Acid Synthesis Inhibitors Phase 4
12 Topoisomerase Inhibitors Phase 4
13
Lactitol Investigational Phase 3,Phase 2 585-86-4 3871
14
Albendazole Approved, Vet_approved Phase 1, Phase 2 54965-21-8 2082
15
Metronidazole Approved Phase 1, Phase 2 443-48-1 4173
16
Secnidazole Approved Phase 1, Phase 2 3366-95-8
17
Zinc Approved, Investigational Phase 1, Phase 2 7440-66-6 23994
18
Zinc sulfate Approved, Investigational Phase 1, Phase 2 7733-02-0
19
Formaldehyde Approved, Vet_approved Phase 2 50-00-0 712
20
Vitamin A Approved, Nutraceutical, Vet_approved Phase 2 11103-57-4, 68-26-8 445354
21 Heptavalent Pneumococcal Conjugate Vaccine Phase 2
22 Pharmaceutical Solutions Phase 1, Phase 2,Not Applicable
23 Anthelmintics Phase 1, Phase 2
24 Antimitotic Agents Phase 1, Phase 2
25 Antiparasitic Agents Phase 1, Phase 2
26 Antiprotozoal Agents Phase 1, Phase 2
27 Astringents Phase 1, Phase 2
28 Dermatologic Agents Phase 1, Phase 2
29 Micronutrients Phase 1, Phase 2
30 Trace Elements Phase 1, Phase 2
31 Antibodies Phase 2,Not Applicable
32 Immunoglobulins Phase 2,Not Applicable
33 Retinol palmitate Phase 2
34 retinol Nutraceutical Phase 2
35
Loperamide Approved Phase 1 53179-11-6 3955
36
Pectin Approved, Investigational, Vet_approved Phase 1 9000-69-5 441476
37 Antidiarrheals Phase 1
38 Gastrointestinal Agents Phase 1
39
Amoxicillin Approved, Vet_approved Not Applicable 26787-78-0 33613
40
Ampicillin Approved, Vet_approved Not Applicable 69-53-4 6249
41
Infliximab Approved 170277-31-3
42 Disinfectants
43 Ether
44 Antirheumatic Agents

Interventional clinical trials:

(show all 42)
# Name Status NCT ID Phase Drugs
1 Typhoid Fever: Combined vs. Single Antibiotic Therapy Unknown status NCT02224040 Phase 4 ceftriaxone;ceftriaxone and azithromycin;azithromycin;azithromycin and cefixime
2 Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood Completed NCT00125047 Phase 4
3 Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China Completed NCT00131833 Phase 4
4 Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam Completed NCT00131820 Phase 4
5 Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever Completed NCT01421693 Phase 4 Ceftriaxone;Gatifloxacin
6 Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever Completed NCT00125008 Phase 4
7 Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort Enrolling by invitation NCT03312699 Phase 4
8 Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects Completed NCT01608815 Phase 3
9 A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Completed NCT01466387 Phase 3
10 Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi Recruiting NCT03299426 Phase 3
11 Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults Completed NCT01438996 Phase 2
12 Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants Completed NCT01437267 Phase 2
13 Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants Completed NCT01229176 Phase 2
14 Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old) Completed NCT01193907 Phase 2
15 Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults Completed NCT00679172 Phase 2
16 TY800 Dose Escalation (Typhoid) Completed NCT00269295 Phase 1, Phase 2 Placebo
17 Studies of Immune Responses to Orally Administered Vaccines in Developing Country Completed NCT01019083 Phase 1, Phase 2 Placebo;Placebo;Zinc Sulphate;Albendazole and Secnidazole
18 Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects Completed NCT00498654 Phase 2
19 Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants Completed NCT00342628 Phase 2
20 Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine Recruiting NCT03527355 Phase 2
21 Vaccines Against Salmonella Typhi Active, not recruiting NCT02324751 Phase 2
22 Understanding Typhoid Disease After Vaccination Active, not recruiting NCT01405521 Phase 2
23 Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine Completed NCT02645032 Phase 1
24 Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old) Completed NCT01123941 Phase 1
25 CVD 909 Vi Prime Boost Study Completed NCT00326443 Phase 1 Placebo
26 Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine Completed NCT00277147 Phase 1 BB IND 6989
27 Reservoir of Invasive Salmonellosis in Children, DRC Completed NCT03073707
28 Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients Completed NCT00002052 Not Applicable Ceftriaxone sodium;Ampicillin sodium;Amoxicillin trihydrate
29 NCCLS Interpretive Criteria for Salmonella Completed NCT00177658
30 Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders Completed NCT02105714
31 Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers Completed NCT02628054 Not Applicable
32 Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers Completed NCT02391909
33 Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age Completed NCT00386789
34 Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035) Completed NCT00705614
35 Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) Completed NCT01766830 Not Applicable
36 Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission Recruiting NCT03494101
37 IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres Recruiting NCT02689193
38 Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India Recruiting NCT03554213
39 Global Genomic and Proteomic Profiling of African Children With Typhoid Fever Recruiting NCT02947295
40 Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study Recruiting NCT02192008 Not Applicable
41 Investigating Typhoid Fever Pathogenesis Active, not recruiting NCT03067961 Not Applicable
42 Understanding Paratyphoid Infection Active, not recruiting NCT02100397 Not Applicable

Search NIH Clinical Center for Salmonellosis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Genetic Tests for Salmonellosis

Anatomical Context for Salmonellosis

MalaCards organs/tissues related to Salmonellosis:

41
Testes, T Cells, Liver, Colon, Lymph Node, Neutrophil, Ovary

Publications for Salmonellosis

Articles related to Salmonellosis:

(show top 50) (show all 626)
# Title Authors Year
1
Potent O-antigen-deficient (rough) mutants of Salmonella Typhimurium secreting Lawsonia intracellularis antigens enhance immunogenicity and provide single-immunization protection against proliferative enteropathy and salmonellosis in a murine model. ( 29976253 )
2018
2
Municipal Wastewater as a Microbial Surveillance Platform for Enteric Diseases: A Case Study for Salmonella and Salmonellosis. ( 29630348 )
2018
3
Incubation period for outbreak-associated, non-typhoidal salmonellosis cases, Minnesota, 2000-2015. ( 29409557 )
2018
4
Diagnosis and Treatment of Human Salmonellosis in Addis Ababa City, Ethiopia. ( 29951540 )
2018
5
International Symposium on Salmonella and salmonellosis. ( 29366459 )
2018
6
Novel Salmonella enterica Serovar Typhimurium Genotype Levels as Herald of Seasonal Salmonellosis Epidemics. ( 29774859 )
2018
7
Climate variability and salmonellosis in Singapore - A time series analysis. ( 29929293 )
2018
8
Campylobacteriosis, Salmonellosis, Yersiniosis, and Listeriosis as Zoonotic Foodborne Diseases: A Review. ( 29701663 )
2018
9
A Quantitative Risk Assessment of Human Salmonellosis from Consumption of Pistachios in the United States. ( 29757010 )
2018
10
Risk Assessment of Salmonellosis from Consumption of Alfalfa Sprouts and Evaluation of the Public Health Impact of Sprout Seed Treatment and Spent Irrigation Water Testing. ( 29341180 )
2018
11
<i>Salmonella</i> and salmonellosis in horses: an overview. ( 29884637 )
2018
12
Looking for new approaches for the use of serology in the context of control programmes against pig salmonellosis. ( 29218859 )
2018
13
A Quantitative Assessment of the Risk of Human Salmonellosis Arising from the Consumption of Pecans in the United States. ( 28812908 )
2017
14
Using Microsimulation to Estimate the Future Health and Economic Costs of Salmonellosis under Climate Change in Central Queensland, Australia. ( 29233795 )
2017
15
Highly suspected cases of salmonellosis in two cats fed with a commercial raw meat-based diet: health risks to animals and zoonotic implications. ( 28738871 )
2017
16
Risk of Salmonellosis from Chicken Parts Prepared from Whole Chickens Sold in Flow Pack Wrappers and Subjected to Temperature Abuse. ( 28800246 )
2017
17
Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020. ( 28935025 )
2017
18
Importation of travel-related infectious diseases is increasing in South Korea: An analysis of salmonellosis, shigellosis, malaria, and dengue surveillance data. ( 28919170 )
2017
19
Impact of Clinical Salmonellosis in Veal Calves on the Recovery of Salmonella in Lymph Nodes at Harvest. ( 28910140 )
2017
20
CXCR3 plays a critical role for host protection against Salmonellosis. ( 28860493 )
2017
21
CASE SERIES: CLINICAL SALMONELLOSIS IN FOUR BLACK RHINOCEROS (DICEROS BICORNIS) CALVES. ( 28749277 )
2017
22
Review of egg-related salmonellosis and reduction strategies in United States, Australia, United Kingdom and New Zealand. ( 28903617 )
2017
23
Immune-Stimulatory and Therapeutic Activity of<i>Tinospora cordifolia</i>: Double-Edged Sword against Salmonellosis. ( 29318160 )
2017
24
Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice. ( 28702137 )
2017
25
Clinical Salmonellosis in a Closed Colony of Blood Donor Cats. ( 29212585 )
2017
26
Water Quality Survey of Splash Pads After A Waterborne Salmonellosis Outbreak--Tennessee, 2014. ( 29154527 )
2017
27
Small animal disease surveillance: GI disease and salmonellosis. ( 28864509 )
2017
28
Extraintestinal Salmonellosis in the Immunocompromised: An Unusual Case of Pyomyositis. ( 29081808 )
2017
29
Disseminated Mycobacterium malmoense and Salmonella Infections Associated with a Novel Variant in NFKBIA. ( 28417298 )
2017
30
Different Age Distribution between Campylobacteriosis and Nontyphoidal Salmonellosis in Hospitalized Korean Children with Acute Inflammatory Diarrhea. ( 28581280 )
2017
31
Turmeric Bioprocessed with Mycelia from the Shiitake Culinary-Medicinal Mushroom Lentinus edodes (Agaricomycetes) Protects Mice Against Salmonellosis. ( 28605325 )
2017
32
Gastric wall and splenic abscess in the background of an invasive salmonellosis caused by Salmonella enteritidis. ( 29150121 )
2017
33
Salmonellosis beyond the gastrointestinal tract: a case series ( 29393612 )
2017
34
Study of antimicrobial resistance and physiological biomarkers with special reference to Salmonellosis in diarrheic foals in Punjab, Pakistan. ( 28784420 )
2017
35
An association between decreasing incidence of invasive non-typhoidal salmonellosis and increased use of antiretroviral therapy, Gauteng Province, South Africa, 2003-2013. ( 28264046 )
2017
36
Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso. ( 28692655 )
2017
37
Biosecurity aspects of cattle production in Western Uganda, and associations with seroprevalence of brucellosis, salmonellosis and bovine viral diarrhoea. ( 29212482 )
2017
38
Chronic Disseminated Salmonellosis in a Patient with Interleukin- 12p40 Deficiency. ( 28723869 )
2017
39
Phenotypic and Molecular Characterization of Salmonella Enteritidis SE86 Isolated from Poultry and Salmonellosis Outbreaks. ( 29106298 )
2017
40
Occupational Distribution of Campylobacteriosis and Salmonellosis Cases - Maryland, Ohio, and Virginia, 2014. ( 28817554 )
2017
41
Understanding the effects of intermittent shedding on the transmission of infectious diseases: example of salmonellosis in pigs. ( 28929911 )
2017
42
Multi-provincial Salmonellosis Outbreak Related to Newly Hatched Chicks and Poults: A Genomics Perspective. ( 29034124 )
2017
43
Modeling the risk of salmonellosis from consumption of pistachios produced and consumed in the United States. ( 28648297 )
2017
44
A Syst-OMICS Approach to Ensuring Food Safety and Reducing the Economic Burden of Salmonellosis. ( 28626454 )
2017
45
The type three secreted effector SipC regulates the trafficking of PERP during Salmonella infection. ( 27078059 )
2016
46
Evaluation of the Immunogenicity of Diphtheria Toxoid Conjugated to Salmonella Typhimurium-Derived OPS in a Mouse Model: A Potential Vaccine Candidate Against Salmonellosis. ( 27660722 )
2016
47
Utilization of plant-derived recombinant human I^-defensins (hBD-1 and hBD-2) for averting salmonellosis. ( 25417183 )
2015
48
Clinical features and outcome of typhoid fever and invasive non-typhoidal salmonellosis in a tertiary hospital in Belgium: analysis and review of the literature. ( 25819116 )
2015
49
Salmonella infective endocarditis. ( 25882489 )
2015
50
Community Incidence of Campylobacteriosis and Nontyphoidal Salmonellosis, France, 2008-2013. ( 26193045 )
2015

Variations for Salmonellosis

Expression for Salmonellosis

Search GEO for disease gene expression data for Salmonellosis.

Pathways for Salmonellosis

Pathways related to Salmonellosis according to GeneCards Suite gene sharing:

(show top 50) (show all 63)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.02 CASP1 DEFB1 DEFB4A IFNG IFNGR1 IL12RB1
2
Show member pathways
13.66 CASP1 IFNG IFNGR1 IL12RB1 IL18 IL1B
3
Show member pathways
13.49 IFNG IFNGR1 IL12RB1 IL18 IL1B JUN
4
Show member pathways
13.36 CASP1 IFNG IFNGR1 IL12RB1 IL18 IL1B
5
Show member pathways
12.96 CASP1 IFNG IFNGR1 IL18 IL1B JUN
6
Show member pathways
12.89 IFNG IFNGR1 IL12RB1 IL18 IL1B STAT1
7 12.84 IFNG IFNGR1 IL12RB1 JUN SPI1 STAT1
8
Show member pathways
12.79 IFNG IFNGR1 IL1B JUN TLR4
9
Show member pathways
12.79 CASP1 IFNG IFNGR1 IL18 IL1B JUN
10
Show member pathways
12.76 CASP1 IFNG IL18 IL1B TLR4
11
Show member pathways
12.67 IFNG IFNGR1 IL1B JUN STAT1
12
Show member pathways
12.67 IFNG IFNGR1 IL12RB1 IL18 IL1B STAT1
13
Show member pathways
12.6 IFNG IL12RB1 IL18 IL1B STAT1
14
Show member pathways
12.55 IFNGR1 JUN STAT1 TLR4
15 12.54 IFNG IL1B SPI1 STAT1
16
Show member pathways
12.52 CASP1 IL1B JUN TLR4
17
Show member pathways
12.34 DEFB4A IFNG IL1B JUN
18
Show member pathways
12.3 IFNG IFNGR1 IL1B JUN STAT1 TLR4
19
Show member pathways
12.26 CP IL18 IL1B JUN STAT1
20 12.25 IFNG IFNGR1 IL18 IL1B STAT1 TLR4
21
Show member pathways
12.23 CASP1 IL1B JUN STAT1
22
Show member pathways
12.23 CASP1 IFNG IFNGR1 IL1B STAT1 TLR4
23 12.2 IFNG IFNGR1 STAT1 TLR4
24
Show member pathways
12.18 IFNG IFNGR1 IL12RB1 IL18 IL1B JUN
25
Show member pathways
12.16 IFNG IFNGR1 IL1B JUN SPI1 STAT1
26
Show member pathways
12.14 IL12RB1 JUN STAT1
27
Show member pathways
12.11 CASP1 IFNG IFNGR1 IL18 IL1B JUN
28
Show member pathways
12.05 IL1B JUN STAT1 TLR4
29 12.02 IFNG IFNGR1 IL1B JUN SPI1 STAT1
30
Show member pathways
12.02 DEFB4A IFNG IFNGR1 IL1B JUN STAT1
31 11.99 IFNG IL1B TLR4
32 11.96 IL18 IL1B STAT1
33
Show member pathways
11.93 IFNG IL12RB1 IL18 IL1B JUN STAT1
34 11.92 IFNG IL1B JUN
35 11.92 IFNG IFNGR1 IL12RB1 STAT1
36 11.92 IFNG IL18 IL1B JUN TLR4
37 11.9 IFNG IFNGR1 TLR4
38 11.89 IL1B JUN STAT1
39 11.87 IFNG IL1B TLR4
40 11.84 IFNG JUN SPI1 STAT1
41 11.84 IFNG IL12RB1 IL18 IL1B SPI1
42
Show member pathways
11.83 IFNG IFNGR1 IL12RB1 IL18 IL1B JUN
43 11.8 CASP1 IL1B JUN TLR4
44 11.75 IFNG IL1B SPI1
45
Show member pathways
11.67 IFNG IL1B JUN
46 11.63 IFNG JUN STAT1
47 11.62 CASP1 IL18 IL1B NLRC4 TLR4
48 11.6 IFNG IL18 IL1B TLR4
49
Show member pathways
11.57 IFNG IFNGR1 JUN
50 11.57 IFNG IL18 IL1B TLR4

GO Terms for Salmonellosis

Cellular components related to Salmonellosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.56 ALB CASP1 CP DEFB1 DEFB4A IFNG
2 IPAF inflammasome complex GO:0072557 8.62 CASP1 NLRC4

Biological processes related to Salmonellosis according to GeneCards Suite gene sharing:

(show all 35)
# Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.96 IL18 IL1B NLRC4 SLC11A1 TLR4
2 positive regulation of gene expression GO:0010628 9.95 IFNG IL18 IL1B SLC11A1 TLR4
3 cellular response to interferon-gamma GO:0071346 9.83 CASP1 IL12RB1 STAT1
4 defense response to bacterium GO:0042742 9.8 DEFB1 DEFB4A NLRC4 SLC11A1 TLR4
5 cellular response to mechanical stimulus GO:0071260 9.79 CASP1 IL1B TLR4
6 cellular response to organic cyclic compound GO:0071407 9.79 IL18 IL1B STAT1
7 interferon-gamma-mediated signaling pathway GO:0060333 9.77 IFNG IFNGR1 STAT1
8 response to lipopolysaccharide GO:0032496 9.77 CASP1 IL1B JUN SLC11A1 TLR4
9 positive regulation of smooth muscle cell proliferation GO:0048661 9.75 IL18 JUN STAT1
10 antimicrobial humoral response GO:0019730 9.74 DEFB1 DEFB4A SLC11A1
11 defense response to Gram-negative bacterium GO:0050829 9.73 DEFB1 DEFB4A SLC11A1 TLR4
12 cytokine-mediated signaling pathway GO:0019221 9.73 CASP1 IFNGR1 IL12RB1 IL18 IL1B STAT1
13 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.71 IL18 IL1B TLR4
14 immune response GO:0006955 9.7 DEFB1 DEFB4A IFNG IL18 IL1B SLC11A1
15 response to ATP GO:0033198 9.67 CASP1 IL1B
16 positive regulation of nitric oxide biosynthetic process GO:0045429 9.67 IFNG IL1B TLR4
17 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.66 IFNG IL1B
18 positive regulation of nitric-oxide synthase biosynthetic process GO:0051770 9.66 STAT1 TLR4
19 positive regulation of interferon-alpha production GO:0032727 9.65 STAT1 TLR4
20 interferon-gamma production GO:0032609 9.65 IL18 TLR4
21 pyroptosis GO:0070269 9.64 CASP1 NLRC4
22 negative regulation of interleukin-17 production GO:0032700 9.64 IFNG TLR4
23 T-helper 1 type immune response GO:0042088 9.63 IL18 TLR4
24 positive regulation of granulocyte macrophage colony-stimulating factor production GO:0032725 9.63 IL18 IL1B
25 lipopolysaccharide-mediated signaling pathway GO:0031663 9.63 IL18 IL1B TLR4
26 macrophage activation GO:0042116 9.62 SLC11A1 TLR4
27 positive regulation of T-helper 1 type immune response GO:0002827 9.61 IL12RB1 SLC11A1
28 interleukin-1 beta secretion GO:0050702 9.59 NLRC4 TLR4
29 interleukin-6 production GO:0032635 9.58 IL18 IL1B
30 interleukin-1 beta production GO:0032611 9.51 CASP1 IL1B
31 regulation of interferon-gamma-mediated signaling pathway GO:0060334 9.5 IFNG IFNGR1 STAT1
32 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.48 IFNG IL1B
33 response to bacterium GO:0009617 9.26 CASP1 DEFB1 SLC11A1 TLR4
34 positive regulation of interferon-gamma production GO:0032729 9.02 IL12RB1 IL18 IL1B SLC11A1 TLR4
35 positive regulation of transcription by RNA polymerase II GO:0045944 10.07 IL18 IL1B JUN SLC11A1 SPI1 STAT1

Molecular functions related to Salmonellosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.5 ALB CASP1 DEFB1 JUN LACTB NLRC4
2 CCR6 chemokine receptor binding GO:0031731 9.16 DEFB1 DEFB4A
3 transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000982 8.8 JUN SPI1 STAT1

Sources for Salmonellosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....